AlphaYouLH
Schedule 13G filing
Lantheus Holdings, Inc. disclosed a 17.3% stake in Radiopharm Theranostics Ltd (RADX)
Lantheus Holdings, Inc. reported owning 17.3% of Radiopharm Theranostics Ltd (RADX) (792,958,513 shares) in a Schedule 13G filed Sep 4, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 4, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.